about
Technical solution for data collection, data safety and data privacy legislation: experiences from the SWEET study.High plasma levels of islet amyloid polypeptide in young with new-onset of type 1 diabetes mellitus.Residual beta cell function at diagnosis of type 1 diabetes in children and adolescents varies with gender and season.A multicenter observational safety study in Swedish children and adolescents using insulin detemir for the treatment of type 1 diabetesConceptions of diabetes and diabetes care in young people with minority backgrounds.Metabolic control in children with insulin-dependent diabetes mellitus 5 y after diagnosis. Early detection of patients at risk for poor metabolic control.Antibodies to influenza virus A/H1N1 hemagglutinin in Type 1 diabetes children diagnosed before, during and after the SWEDISH A(H1N1)pdm09 vaccination campaign 2009-2010.Decline of C-peptide during the first year after diagnosis of Type 1 diabetes in children and adolescents.The reliability and validity of the revised Diabetes Family Conflict Scale questionnaire, in a sample of Swedish children.Diabetes management in Swedish schools: a national survey of attitudes of parents, children, and diabetes teams.Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.Health-related quality of life in preschool children with Type 1 diabetes.Detection and treatment efficacy of hypoglycemic events in the everyday life of children younger than 7 yr.Influence of the initial management regimen and family social situation on glycemic control and medical care in children with type I diabetes mellitus.Insulin Receptor and the Kidney: Nephrocalcinosis in Patients with Recessive INSR MutationsThe delivery of ambulatory diabetes care to children and adolescents with diabetesChildren under the age of seven with diabetes are increasing their cardiovascular risk by their food choices[My three mothers--on children's right to know their origin]Family-oriented support at the onset of diabetes mellitus: a comparison of two group conditions during 2 years following diagnosisISPAD Clinical Practice Consensus Guidelines 2018: Management and support of children and adolescents with type 1 diabetes in schoolPersistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective
P50
Q30559755-5721D3F0-430E-4245-8B64-D3B6BDB398E8Q35132136-A70447F2-DADB-47FA-9180-02962A5E481AQ36818038-E3A46093-E644-4036-B9A5-13FA9F32C034Q37261870-3FE301E6-9DE1-467A-9BD4-301159EBFD9BQ39135516-5FECC856-D5EE-4C85-A8F1-0ED8CBAF96DAQ40843393-E32CF0E6-3454-4CC0-B33F-18ADBEDD1068Q42250705-205154FF-2902-4841-B091-929CF229129AQ44394408-D8B11A28-1CEE-4B61-9E33-11BFD3264DFBQ44438745-B435BF07-3569-4D31-BB69-AAA394B3787CQ45825657-A620BE33-5529-4C98-BC32-F1B57DA2E3DBQ46115645-EB18B6A3-EBAC-4F15-90F7-D6E8A7B7C9C8Q48069411-C501D389-E070-4AAF-9D42-5400D64FB6F4Q50736577-B3DA0C25-0089-4BA7-9FBB-D7A48542FD71Q52140161-C6E5CDF1-C690-4D88-81CA-3F94B822263FQ58035793-3F2CDB15-3ECC-43FC-83BB-1754868861B5Q63444440-BD4C349B-E3C5-438E-A30A-498076D0B218Q63444442-6F50BCDD-380F-47E0-A651-0BD9AF1B76E6Q63444447-69E628B1-936D-4153-9A72-4E381C6ECA28Q63444448-34A473E8-14B3-436B-9245-A0BBFD6F84EFQ90801602-42D8B590-7857-41E3-B855-82E6C3BFC550Q91658881-DBF963D1-C096-41DF-A7CA-6AF9FD665883
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gun Forsander
@ast
Gun Forsander
@en
Gun Forsander
@es
Gun Forsander
@nl
Gun Forsander
@sl
type
label
Gun Forsander
@ast
Gun Forsander
@en
Gun Forsander
@es
Gun Forsander
@nl
Gun Forsander
@sl
prefLabel
Gun Forsander
@ast
Gun Forsander
@en
Gun Forsander
@es
Gun Forsander
@nl
Gun Forsander
@sl
P106
P2038
Gun_Forsander
P21
P31
P496
0000-0002-0266-9651
P6634
gun-forsander-2739a250